Why ResMed (RMD) is Poised to Beat Earnings Estimates Again
ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks·18h ago
More News
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Zacks·21h ago
Lbp Am Sa Buys 18,142 Shares of ResMed Inc. $RMD
Lbp Am Sa boosted its stake in shares of ResMed Inc. (NYSE:RMD - Free Report) by 364.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 23,125 shares of the medical equipment provider's stock after acquiring an additi...
MarketBeat·3d ago
Should You Continue to Hold Resmed Stock in Your Portfolio?
RMD's growth strategy, rising device demand and solid finances support momentum, but macro pressures and stiff competition could test its outlook.
Zacks·4d ago
KBC Group NV Has $57.23 Million Position in ResMed Inc. $RMD
KBC Group NV boosted its stake in shares of ResMed Inc. (NYSE:RMD - Free Report) by 126.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission...
MarketBeat·4d ago
Hendershot Investments Inc. Increases Holdings in ResMed Inc. $RMD
Hendershot Investments Inc. grew its holdings in ResMed Inc. (NYSE:RMD - Free Report) by 14.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange...
MarketBeat·4d ago
Here are Thursday's biggest analyst calls: Nvidia, Apple, Tesla, CoreWeave, Meta, Dick's, ResMed & more
Here are Thursday's biggest analyst calls on Wall Street...
CNBC: Top News·5d ago
ResMed (NYSE:RMD) Now Covered by JPMorgan Chase & Co.
JPMorgan Chase & Co. started coverage on ResMed in a research note on Wednesday. They set an "overweight" rating on the stock...
MarketBeat·6d ago
ResMed Inc. $RMD Shares Sold by Robeco Institutional Asset Management B.V.
Robeco Institutional Asset Management B.V. decreased its stake in shares of ResMed Inc. (NYSE:RMD - Free Report) by 15.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 60,661 shares of the medical equipment provider's stock after selling 11,194 shares...
MarketBeat·6d ago
ResMed Inc. $RMD Shares Sold by Sumitomo Mitsui Trust Group Inc.
Sumitomo Mitsui Trust Group Inc. lowered its position in ResMed Inc. (NYSE:RMD - Free Report) by 3.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The...